Clinical Site

Bellevue, Washington 98007

3 studies enrolling now · 8 studies all time

What they study most

Age-Related Macular Degeneration, Bipolar Depression, Celiac Disease, Generalized Anxiety Disorder, Major Depressive Disorder, Neovascular Age-related Macular Degeneration, Psychosis Associated With Alzheimer's Disease, Wet Macular Degeneration

Studies at this site

• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis — Recruiting now
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder — Completed